Applied StemCell has developed an efficient integration-free, small molecule-based method to
differentiate high-quality hematopoietic progenitor cells (HPC) from human iPSCs. The
differentiated HPCs recapitulate the phenotype and functional parameters of primary and in vivo HPCs.
We provide HPCs differentiated from an integration-free, control human iPSC line (ASE-9211),
reprogrammed from the fibroblasts of an African-American male donor. These high-purity (≥70%) cells express high levels of HPC biomarker, CD34.